Literatur
-
01 Jauch KW. Delayed introduction of a calcineurin-inhibitor (CNI)-free sirolimus (SRL)-based immunosuppression in renal transplantation is safe. Preliminary results of the randomised mulitcenter SMART trial. XXII International Congress of The Transplantation Society (ICTS) 2008; Mini-Oral Session 18 WMO 18.
01 Sirolimus and MMF After Renal Transplantation